🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchClinicalTrials.gov GLP-1 trial tracker — updated weekly Page 17

ClinicalTrials.gov GLP-1 trial tracker — updated weekly

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 411 replies 11,865 viewsPage 17 of 20
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Aug 1, 2025 at 6:21 AM#81

Closing the loop on my own question.

Update, and it is the boring outcome: nothing was wrong. The measurement I was reading had moved less than its own week-to-week variation, which somebody said upthread and I did not believe.

14 12Dr.EM_Chicago, pete_RVA, CarlaRPh_TPA and 11 others
Reply Quote Save Share Report
NurseKim_ATL
Senior Member
1,678
7,234
Feb 2024
Atlanta, GA
Aug 9, 2025 at 6:04 AM#82

From the other side of the consultation, briefly. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Last edited: Aug 9, 2025 at 11:04 AM
15 13raj_cambridge, ingrid_STO, pete_nash and 12 others
Reply Quote Save Share Report
lucas_SP_BR
Member
456
1,890
Jun 2024
São Paulo, BR
Aug 17, 2025 at 5:42 AM#83
NurseKim_ATL said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Adding a me-too, because a thread of one person's experience is not much use.

Last edited: Aug 17, 2025 at 7:42 AM
16 14zoe_NC, Dr.ObesityLA, NurseKim_ATL and 13 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
NauseaFreeNow
Member
345
1,234
Aug 2024
Indiana
Aug 25, 2025 at 5:15 AM#84
NurseKim_ATL said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Coming at NurseKim_ATL’s question from a different direction. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

Last edited: Aug 25, 2025 at 9:15 AM
17 15lori_vegas, Dr.PulmRoch, maya_sedona and 14 others
Reply Quote Save Share Report
LabKate
Senior Member
2,678
11,234
Jan 2024
Oregon
Sep 2, 2025 at 4:44 AM#85

One concrete data point for the thread. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

Last edited: Sep 2, 2025 at 7:44 AM
18 16labquiet_amy, emily_PDX, Dr.SleepRoch and 15 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register